Literature DB >> 2497621

Ia-expressing microglial cells in experimental allergic encephalomyelitis in rats.

H Konno1, T Yamamoto, Y Iwasaki, T Saitoh, H Suzuki, H Terunuma.   

Abstract

Monoclonal antibodies (MRC OX-6 and OX-17) recognized three types of cells expressing Ia antigen during the course of acute experimental allergic encephalomyelitis (EAE) in rats. In earlier stages of the disease, in animals with or without paralysis, Ia antigens were mostly localized to subarachnoidal and perivascular lymphocytic and histiocytic cell infiltrates, possibly serving as antigen-presenting cells. On the other hand, in convalescent rats, Ia antigens were expressed in a large number of cells with dendritic processes heavily populating the spinal gray matter. The appearance of these Ia-expressing cells in the convalescent stage coincided with the development of degenerating axon terminals in the spinal gray matter. These Ia-expressing cells possessed morphological features characteristic of microglia and were positive for ML-1 lectin but did not express glial fibrillary acidic protein. Immune electron microscopy disclosed the presence of Ia reaction products in the Golgi apparatus, endoplasmic reticulum and plasma membrane of these cells with dendritic processes, indicating active synthesis of Ia molecules in microglia. In addition, Ia antigens were localized to the cells with ultrastructural features of macrophages. Thus, Ia-expressing cells in EAE seems to play dual roles: the induction of immunological reactions during earlier stages and the participation in reparative processes during convalescence.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2497621     DOI: 10.1007/bf00687248

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  24 in total

1.  Acute experimental allergic encephalomyelitis in the mouse: immunopathology of the developing lesion.

Authors:  U Traugott; C S Raine; D E McFarlin
Journal:  Cell Immunol       Date:  1985-03       Impact factor: 4.868

2.  Identification of the normal microglial population in human and rodent nervous tissue using lectin-histochemistry.

Authors:  H Suzuki; H Franz; T Yamamoto; Y Iwasaki; H Konno
Journal:  Neuropathol Appl Neurobiol       Date:  1988 May-Jun       Impact factor: 8.090

3.  Biochemical analysis of class II antigens. Identification of a two- and a three-polypeptide chain complex of I-A locus equivalent molecules in the rat.

Authors:  J Bayer; K Reske
Journal:  Eur J Immunol       Date:  1983-01       Impact factor: 5.532

4.  The immunopathology of experimental allergic encephalomyelitis. II. Endothelial cell Ia increases prior to inflammatory cell infiltration.

Authors:  R A Sobel; B W Blanchette; A K Bhan; R B Colvin
Journal:  J Immunol       Date:  1984-05       Impact factor: 5.422

5.  Immunohistochemical analysis of the cellular infiltrate in multiple sclerosis lesions.

Authors:  S L Hauser; A K Bhan; F Gilles; M Kemp; C Kerr; H L Weiner
Journal:  Ann Neurol       Date:  1986-06       Impact factor: 10.422

6.  The immunopathology of acute experimental allergic encephalomyelitis. IV. An ultrastructural immunocytochemical study of class II major histocompatibility complex molecule (Ia) expression.

Authors:  R A Sobel; J M Natale; E E Schneeberger
Journal:  J Neuropathol Exp Neurol       Date:  1987-05       Impact factor: 3.685

7.  Immunologically discrete conformation isomers of I-A locus-equivalent class II molecules detected in Lewis rats.

Authors:  K Reske; R Weitzel
Journal:  Eur J Immunol       Date:  1985-12       Impact factor: 5.532

8.  Initial response of silver-impregnated "resting microglia" to stab wounding in rabbit hippocampus.

Authors:  T Kitamura; Y Tsuchihashi; S Fujita
Journal:  Acta Neuropathol       Date:  1978-10-13       Impact factor: 17.088

9.  Dynamic aspects of glial reactions in altered brains.

Authors:  T Kitamura
Journal:  Pathol Res Pract       Date:  1980       Impact factor: 3.250

10.  Anti I-A antibody suppresses active encephalomyelitis: treatment model for diseases linked to IR genes.

Authors:  S Sriram; L Steinman
Journal:  J Exp Med       Date:  1983-10-01       Impact factor: 14.307

View more
  7 in total

1.  Lesion of the rat entorhinal cortex leads to a rapid microglial reaction in the dentate gyrus. A light and electron microscopical study.

Authors:  J Gehrmann; S W Schoen; G W Kreutzberg
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

Review 2.  The role of macrophage subpopulations in autoimmune disease of the central nervous system.

Authors:  J Bauer; S R Ruuls; I Huitinga; C D Dijkstra
Journal:  Histochem J       Date:  1996-02

3.  Targeting of adoptively transferred experimental allergic encephalitis lesion at the sites of wallerian degeneration.

Authors:  H Konno; T Yamamoto; H Suzuki; H Yamamoto; Y Iwasaki; Y Ohara; H Terunuma; N Harata
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

Review 4.  [Update on pathophysiologic and immunotherapeutic approaches for the treatment of multiple sclerosis].

Authors:  C Kleinschnitz; S G Meuth; B C Kieseier; H Wiendl
Journal:  Nervenarzt       Date:  2007-08       Impact factor: 1.214

5.  Immunophenotypic evidence for distinct populations of microglia in the rat hypothalamo-neurohypophysial system.

Authors:  T H Mander; J F Morris
Journal:  Cell Tissue Res       Date:  1995-06       Impact factor: 5.249

6.  Activation and re-expression of surface antigen in microglia following an epidural application of kainic acid in the rat brain.

Authors:  C Kaur; E A Ling
Journal:  J Anat       Date:  1992-04       Impact factor: 2.610

7.  Glial pathology and retinal neurotoxicity in the anterior visual pathway in experimental autoimmune encephalomyelitis.

Authors:  Jing Jin; Matthew D Smith; Calvin J Kersbergen; Tae-In Kam; Mayuri Viswanathan; Kyle Martin; Ted M Dawson; Valina L Dawson; Donald J Zack; Katharine Whartenby; Peter A Calabresi
Journal:  Acta Neuropathol Commun       Date:  2019-07-31       Impact factor: 7.801

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.